P

Inventor

RILEY TIMOTHY A

US48 patents
⚠️ This page may combine multiple inventors who share the name “RILEY TIMOTHY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NEKTAR THERAPEUTICS

23 patents
US9233167B2Jan 12, 2016

Oligomer-opioid agonist conjugates

NEKTAR THERAPEUTICS7 citations92
US9233168B2Jan 12, 2016

Oligomer-opioid agonist conjugates

NEKTAR THERAPEUTICS7 citations92
US8952032B2Feb 10, 2015

Oligomer-opioid agonist conjugates

NEKTAR THERAPEUTICS9 citations92
US8946285B2Feb 3, 2015

Oligomer-opioid agonist conjugates

NEKTAR THERAPEUTICS9 citations92
US9512135B2Dec 6, 2016

Oligomer-opioid agonist conjugates

NEKTAR THERAPEUTICS4 citations84
US9458166B2Oct 4, 2016

Oligomer-opioid agonist conjugates

NEKTAR THERAPEUTICS4 citations84
US10098865B2Oct 16, 2018

Multi-arm polymeric prodrug conjugates of taxane-based compounds

NEKTAR THERAPEUTICS4 citations73
US10189859B2Jan 29, 2019

Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

NEKTAR THERAPEUTICS2 citations70
US9925182B2Mar 27, 2018

Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound

NEKTAR THERAPEUTICS3 citations69
US9457024B2Oct 4, 2016

Compositions, dosage forms, and co-administration of an opioid agonist compound and a non-steroidal anti-inflammatory drug

NEKTAR THERAPEUTICS4 citations69
US11813241B2Nov 14, 2023

Multi-arm polymeric prodrug conjugates of taxane-based compounds

NEKTAR THERAPEUTICS0 citations63
US10143690B2Dec 4, 2018

Oligomer-opioid agonist conjugates

NEKTAR THERAPEUTICS1 citations63
US10512644B2Dec 24, 2019

Oligomer-opioid agonist conjugates

NEKTAR THERAPEUTICS0 citations52
US10231984B2Mar 19, 2019

Oligomer-foscarnet conjugates

NEKTAR THERAPEUTICS0 citations52
US9827239B2Nov 28, 2017

Oligomer-opioid agonist conjugates

NEKTAR THERAPEUTICS0 citations52
US9670235B2Jun 6, 2017

Oligomer-foscarnet conjugates

NEKTAR THERAPEUTICS0 citations52
US9149538B2Oct 6, 2015

Oligomer conjugates of heteropentacyclic nucleosides

NEKTAR THERAPEUTICS0 citations52
US8778898B2Jul 15, 2014

Oligomer conjugates of heteropentacyclic nucleosides

NEKTAR THERAPEUTICS0 citations52
US9365604B2Jun 14, 2016

Oligomer-nucleoside phosphate conjugates

NEKTAR THERAPEUTICS1 citations50
US10844076B2Nov 24, 2020

Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

NEKTAR THERAPEUTICS0 citations49
US10806794B2Oct 20, 2020

Protease inhibitors having enhanced features

NEKTAR THERAPEUTICS0 citations49
US10092656B2Oct 9, 2018

Protease inhibitors having enhanced features

NEKTAR THERAPEUTICS0 citations49
US10525054B2Jan 7, 2020

Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound

NEKTAR THERAPEUTICS0 citations48

RIGGS-SAUTHIER JENNIFER

4 patents

GENTA INC

4 patents

ZEVEX INC

3 patents

RILEY TIMOTHY A

3 patents

CHIMERIX INC

2 patents

MCMANUS SAMUEL P

2 patents

REN ZHONGXU

1 patent

OASIS BIOSCIENCES INC

1 patent

(unassigned)

1 patent

BROWN BOB D

1 patent

Nektar Therapeuitcs

1 patent

GEN PROBE INC

1 patent

DENG BO-LIANG

1 patent